C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
11/2009
11/26/2009	WO2009143404A1 Piperazine metabotropic glutamate receptor 5 (mglur5) negative allosteric modulators for anxiety/depression
11/26/2009	WO2009141386A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
11/26/2009	US20090292122 Process for the preparation of cyano-substituted-nitrogen-containing heteroaryl compounds
11/26/2009	US20090291960 Pyrrolinidium derivatives as m3 muscarinic receptors
11/26/2009	CA2725185A1 Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
11/25/2009	EP2123276A1 Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
11/25/2009	EP2122739A1 Nitroxides for lithium-ion batteries
11/25/2009	EP2121637A1 Anthranilamide inhibitors of aurora kinase
11/25/2009	EP2121633A2 Piperazine derivatives for treatment of ad and related conditions
11/25/2009	CN101589026A Method of treatment of glioma brain tumour
11/25/2009	CN101584691A Compounds effecting glucokinase
11/24/2009	US7622497 Such as -(Morpholin-4-yl)-ethyl gambogate; 2-Dimethylaminoethyl gambogate; N-[3-(4-Methyl-piperazin-1-yl)-propyl]gambogamide;N-(3-Morpholin-4-yl-propyl)gambogamide; Methyl 37,38-Dihydroxy-gambogate; Methyl 37,38-Dihydroxy-9,10-dihydro-10-morpholinyl-gambogate; anticarcinogenic agent
11/24/2009	US7622056 Pyridyl derivatives with substituents of electrons push-pull effect; compounds are colorless and have high thermal and photo stability as well as high compatibility in liquid crystal host; can reduce threshold voltage of cholesteric reflective displays, saving power and extending lifetime of driver ICs
11/24/2009	CA2541832C Substituted 2h-[1,2,4]triazolo[4,3-a]pyrazines as gsk-3 inhibitors
11/24/2009	CA2385882C Tyrosine derivatives
11/19/2009	WO2009139886A2 Targeting an hiv-1 nef-host cell kinase complex
11/19/2009	WO2009138378A1 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of arway diseases
11/19/2009	US20090286976 One-pot synthesis of fluorinated ionic liquids
11/19/2009	US20090286968 2-Quinoxalinol Salen Compounds and Uses Thereof
11/19/2009	US20090286809 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/19/2009	US20090286807 Cyclic amine compound
11/19/2009	US20090286801 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands
11/19/2009	US20090286794 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/19/2009	US20090286771 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
11/19/2009	US20090286261 Method for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin d synthase
11/19/2009	US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009	CA2723938A1 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases
11/18/2009	EP2119709A1 Method for producing optically active 2-arylpiperazine derivative
11/18/2009	CN101583599A N-hydroxyacrylamide compounds
11/18/2009	CN101580494A Method for extracting phenazine from RT base production waste
11/17/2009	US7619050 Acrylic acid 2-[2-(2,6-diethyl-4-hydroxy-2,3,6-trimethyl-piperidin-1-yloxy)-propionyloxy]-ethyl ester; macroinitiators/regulators containing unsaturation, acrylic esters; macromolecular monomers; designing nanoscopic graft polymers; reversible capping of propagating radicals; complex polymers
11/17/2009	US7618978 Amides as BACE inhibitors
11/17/2009	CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009	CA2450801C Drugs that enhance synaptic responses mediated by ampa receptors
11/17/2009	CA2441239C Mch antagonists and their use in the treatment of obesity
11/17/2009	CA2407094C Diazabicyclic central nervous system active agents
11/12/2009	WO2009137596A1 Substituted amides, method of making, and use as btk inhibitors
11/12/2009	WO2009135526A1 Alpha-mercapto-amides
11/12/2009	WO2009100261A3 Improved process for making triphenylboron-pyridine compound
11/12/2009	WO2009083532A3 Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained, and uses thereof
11/12/2009	WO2009080745A3 Perhydroquinoxaline derivatives as analgesics
11/12/2009	US20090281318 Process for preparation of substantially optically pure levorotatory and dextrorotatory enantiomers of cetirizine using novel intermediates
11/12/2009	US20090281109 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
11/12/2009	US20090281087 Compounds II
11/12/2009	CA2723550A1 Alpha-mercapto-amides
11/12/2009	CA2723237A1 Substituted amides, method of making, and use as btk inhibitors
11/11/2009	EP2116535A1 Glucokinase-activating substance
11/11/2009	EP2116533A1 Glucokinase activator
11/11/2009	EP2116526A1 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors
11/11/2009	EP2114948A2 Inhibitors of poly(adp-ribose)polymerase
11/11/2009	EP1427418B1 Piperazinone compounds as anti-tumor and anti-cancer agents
11/11/2009	EP1397351B1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
11/11/2009	EP1339673B1 Malonamide and malonamic ester derivatives with antithrombotic activity, their preparation and their use
11/11/2009	EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/11/2009	CN101575352A Light emitting element and light-emitting device
11/11/2009	CN100558722C A method for the preparation of enantiomerically pure mirtazapine
11/11/2009	CN100558715C Protein kinase inhibitors
11/11/2009	CN100558713C Pyridazine derivatives and their use as therapeutic agents
11/11/2009	CN100558697C Cycloalkyl inhibitors of potassium channel function
11/10/2009	US7615640 Merocyanine dyes; solar cells
11/10/2009	US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009	US7615557 Such as 1-(2-Chlorophenyl)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)piperidine-4-carboxamide; vanilloid receptor antagonists; urological disorders; inflammation; urinary incontinence; benign prostatic hyperplasia
11/10/2009	US7615556 Piperazinyl derivatives as modulators of chemokine receptor activity
11/10/2009	US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009	CA2371213C Inhibitors of carboxypeptidase u
11/05/2009	WO2009133687A1 Cyclopentylacrylic acid amide derivative
11/05/2009	WO2009132739A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/05/2009	WO2009132453A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009	WO2009132452A1 Diaryl-cyclylalkyl derivatives as calcium channel blockers
11/05/2009	US20090275749 Production method of optically active piperazine compound
11/05/2009	US20090275588 Novel sulfonamide compounds
11/05/2009	US20090274657 Difluoromethyl-containing macrocyclic compounds as hepatitis c virus inhibitors
11/05/2009	US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/05/2009	CA2722813A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/05/2009	CA2722733A1 Cyclopentylacrylamide derivative
11/05/2009	CA2722704A1 Cyclylamine derivatives as calcium channel blockers
11/04/2009	EP2113133A1 Light-emitting element, light-emitting device, electronic device and quinoxaline derivative
11/04/2009	EP1446387B1 Substituted aryl 1,4-pyrazine derivatives
11/04/2009	EP1339684B1 Mch antagonists and their use in the treatment of obesity
11/04/2009	EP1253152B1 Method of converting functional group through halogen-metal exchange reaction
11/04/2009	CN101570517A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
11/03/2009	US7612204 Quinoxaline derivative, and light-emitting element and light-emitting device using quinoxaline derivative
11/03/2009	US7612075 Anticaogulants; cardiovascular disorders
11/03/2009	CA2443724C Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/03/2009	CA2442423C Therapeutic drug for psychoneurotic disorders
11/03/2009	CA2420585C Amides of r-2-(aminoaryl)-propionic acids for use in the prevention of leucocyte activation
10/2009
10/29/2009	WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009	WO2009130873A1 Hydroalkane sulfonate and use thereof
10/29/2009	WO2009129726A1 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture
10/29/2009	WO2009109782A3 Polycyclic organic compounds, retardation layer and compensation panel based thereon
10/29/2009	US20090270616 Aryl sulfonamides
10/29/2009	US20090270421 Inhibitors of fatty acid amide hydrolase
10/29/2009	US20090270416 N-OXIDES OF DIARYLUREA DERIVATIVES AND THEIR USE AS Chk1 INHIBITORS FOR THE TREATMENT OF CANCER
10/29/2009	US20090270410 Benzazole analogues and uses thereof
10/29/2009	US20090270409 Compounds and compositions as modulators of gpr119 activity
10/29/2009	US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009	US20090269846 Inhibitors of tyrosine kinase receptor dimerization
10/29/2009	CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/28/2009	CN101565409A Piperazidine or homopiperazine oxalyl hydrazine class compound, preparation and use thereof
10/28/2009	CN100554266C Aryl piperazine modified benzo [b] thiophene compound, and its preparing method and use

1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 187